ADO antibody (AA 171-270)
Quick Overview for ADO antibody (AA 171-270) (ABIN748418)
Target
See all ADO AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 171-270
-
Predicted Reactivity
- Human,Mouse,Rat,Dog,Cow
-
Purification
- Purified by Protein A.
-
Immunogen
- KLH conjugated synthetic peptide derived from human ADO
-
Isotype
- IgG
-
-
-
-
Application Notes
-
IHC-P 1:200-400
IHC-F 1:100-500
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200 -
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 μg/μL
-
Buffer
- 0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.
-
Preservative
- ProClin
-
Precaution of Use
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
Storage
- 4 °C,-20 °C
-
Storage Comment
- Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.
-
Expiry Date
- 12 months
-
-
- ADO (2-Aminoethanethiol (Cysteamine) Dioxygenase (ADO))
-
Alternative Name
- ADO
-
Background
-
Synonyms: 2-aminoethanethiol dioxygenase, 2-aminoethanethiol cysteamine dioxygenase, ADO, C10ORF22, DKFZp564C046, FLJ14547, Gm237, MGC67243, MGC73511, RGD1308233, AEDO_HUMAN.
Background: Human thiol dioxygenases include cysteine dioxygenase (CDO, MIM 603943) and cysteamine (2-aminoethanethiol) dioxygenase (ADO, EC 1.13.11.19). CDO adds 2 oxygen atoms to free cysteine, whereas ADO adds 2 oxygen atoms to free cysteamine to form hypotaurine (Dominy et al., 2007 [PubMed 17581819]).[supplied by OMIM]
-
Gene ID
- 84890
Target
-